CD109 and skin squamous cell carcinoma: Consistent with this hypothesis, the release of CD109 by bone marrow mesenchymal stem cells has recently been shown to attenuate EMT in skin squamous cell carcinoma [45], and AMFR plays an important role in regulation of the anti-cancer immune Stimulator of interferon genes (STING) pathway [46].